Stelis Biopharma’s CDMO partner receives approval for a key ANDA from the USFDA
Stelis Biopharma is pleased to announce that its CDMO partner has received ap
View Detail
Stelis’ flagship facility receives Establishment Inspection Report from USFDA for Drug Product Manufacturing
Stelis Biopharma Limited, the biologics arm of Strides Pharma Science Limited
Stelis Biopharma receives EU-GMP certification for two of its manufacturing facilities
Stelis Biopharma, the biologics arm of Strides Pharma Science announced that
Stelis starts next phase of investment into its biologics manufacturing facility
This phase sees the CDMO start work on installing two 2,000-L single-use bior
Stelis concludes US$ 195m Series B and Series C fund raise
Stelis Biopharma (Stelis) today announced that it has successfully concluded